1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Neurocytoma: new trials by email Literature Review of Neurocytoma trials Research Report on Neurocytoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma Mirdametinib - Low-Grade Glioma, Recurrent Low-Grade Glioma | Phase 1 / Phase 2 | Recruiting | St. Jude Children's Research Hospital | 132 | 2021-06-21 | 2026-09-11 |
Astrocytoma (1) · Ganglioglioma (1) · Ganglioneuroma (1) · Neoplasms, Neuroepithelial (1) · Oligodendroglioma (1)
Brain Diseases (1) · Brain Neoplasms (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Glioma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1) · Neuroectodermal Tumors (1)
mirdametinib (1)
St. Jude Children's Research Hospital (1)
United States (1)
Anna Vinitsky, MD, MS (1) · Giles W. Robinson, MD (1)